Navigation Links
Lung Cancer Study Reveals Similar Outcomes for African-American and Caucasian Patients Treated With Alimta®
Date:9/20/2011

and usually go away before the next treatment. Rarely, these reactions may be severe (can lead to Stevens-Johnson syndrome or toxic epidermal necrolysis) and could lead to death. Call your doctor if you get a severe rash, itching, or blistering.

Talk with your doctor, nurse, or pharmacist about any side effect that bothers you or that doesn't go away.

These are not all the side effects of ALIMTA. For more information, ask your doctor, nurse, or pharmacist.

How is ALIMTA given?

ALIMTA is slowly infused (injected) into a vein. The injection or infusion will last about 10 minutes. You will usually receive ALIMTA once every 21 days (3 weeks).

For more information about all of the side effects of ALIMTA, please talk with your healthcare team, see the Patient Prescribing Information and full Prescribing Information, visit www.ALIMTA.com, or call 1-800-545-5979.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

(1)  American Cancer Society. "Cancer Facts & Figures 2011." http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2011 (Accessed August 3, 2011)

(2)  National Cancer Institute, "Cancer Health Disparities Fact Sheet." http://www.cancer.gov/cancertopics/factsheet/disparities/cancer-health-disparities (Accessed August 16, 2011)

(3)  World Health Organization. "Cancer."

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation (NYSE: ... the annual EuroPCR Scientific Program May 21-24 in ... to present a particularly rich and diversified set of ... Dawkins , M.D., global chief medical officer, Boston ... be presented, including the NG PROMUS trial, which evaluated ...
(Date:5/16/2013)... , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... W. Robin , is scheduled to present at the ... York at the Sheraton New York Hotel on ... The presentation will be accessible via a Webcast through ... of the Nektar website: http://www.nektar.com . This Webcast will ...
(Date:5/16/2013)... , May 16, 2013  Amgen (NASDAQ: ... Conference on Tuesday, May 21, 2013, at the Sheraton New ... , beginning at 10:00 a.m. Eastern Daylight Time. ... of Research and Development at Amgen, will present at the ... the Events Calendar on Amgen,s website, www.amgen.com , under ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... Mass., Jan. 5, 2011 Avaxia Biologics, Inc., ... technology to deliver orally-active antibodies to the gastrointestinal ... pre-clinical data in animal models of inflammatory bowel ... significantly reduced disease severity in three different animal ...
... Transposagen Biopharmaceuticals, Inc. (Transposagen), a leader ... entered into a non-exclusive license agreement with Cellular ... human induced pluripotent stem (iPS) cell lines and tissue ... The license agreement allows CDI to use Transposagen,s ...
Cached Medicine Technology:Avaxia Biologics, Inc. to Present Key Pre-Clinical Inflammatory Bowel Disease Remission Data at Biotech Showcase 2011 2Transposagen and Cellular Dynamics International Cross-License Technologies for Induced Pluripotent Stem Cells 2Transposagen and Cellular Dynamics International Cross-License Technologies for Induced Pluripotent Stem Cells 3
(Date:5/20/2013)... Los Angeles, CA (PRWEB) May 20, 2013 ... 2013) – MessageSolution, an industry leader in enterprise-class ... of MessageSolution Enterprise eDiscovery Platform 7.0, the latest ... to address all facets of the legal discovery ... May 21-22 in Los Angeles CA. , As ...
(Date:5/20/2013)... May 20, 2013 InVite® Health, a ... announced the introduction of its new Greens Hx™ ... high density nutrition with plant extracts from 39 super ... royal jelly, apple pectin, plant enzymes and non-dairy probiotics. ... micronutrients and antioxidant levels of several servings of vegetables. ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 The transvaginal ... medical device law firm, report that two important bellwether ... months in state and federal litigations established for C.R. ... 11th, the first C.R. Bard bellwether trial will begin ... District of West Virginia. (In re: C.R. Bard, ...
(Date:5/20/2013)... Today is the last day to register ... tomorrow. Job seekers cannot afford to miss this ... will show job seekers what hiring managers are looking ... the perfect interview answers to the four most common ... get them hired. Job seekers will be able to ...
(Date:5/19/2013)... May 20, 2013 California has one of ... and employers are quickly discovering that comprehensive background checks are ... a job. Driving records can paint an ... if that person has any DUI arrests, speeding offenses, and ... employers are lining up to experience 4SafeDrivers.com, a new online ...
Breaking Medicine News(10 mins):Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 2Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 4Health News:Today Is the Last Day to Register for Tomorrow’s Perfect Interview Answers Webinar From Career Confidential 2Health News:4SafeDrivers.com Announces Driving Record Searches for California Employers 2
... can deliver organized follow-up care for depression effectively and ... Group Health patients that the Journal of General ... After five months, compared to the half of ... half who had three online care management contacts with ...
... WEDNESDAY, March 16 (HealthDay News) -- Newly proposed national ... from power plants could prevent as many as 17,000 ... to the U.S. Environmental Protection Agency. The proposed ... a court deadline, could also prevent 120,000 cases of ...
... French . , Toronto (March 16, 2011) ... received $16 million in funding. The studies, co-funded by the ... Agency (CSA), were announced today at the University of Toronto ... Jane Aubin, Scientific Director of the Canadian Institutes of Health ...
... HealthDay Reporter , TUESDAY, March 15 (HealthDay ... chatting on cell phones while crossing the street, because ... age group than for college students. In laboratory ... aged 59 to 81 and 18 undergraduates aged 18 ...
... 2011 -- Children and adolescents growing up with inflammatory bowel ... study by researchers at McMaster University and the McMaster Children,s ... Pediatrics online, shows children and youth with the most ... 25 per cent lower than other children their age, and ...
... , TUESDAY, March 15 (HealthDay News) -- The cholera ... the 400,000 cases predicted by the United Nations, new study ... cases of the potentially deadly diarrheal disease -- an estimated ... to researchers at the University of California, San Francisco and ...
Cached Medicine News:Health News:Online messaging delivers follow-up care for depression 2Health News:EPA Proposes Tougher Air Pollution Rules for Power Plants 2Health News:Important funding for nanomedicine research to improve diagnosis and treatment 2Health News:Important funding for nanomedicine research to improve diagnosis and treatment 3Health News:Crossing Street While on Cell Phone Risky for Seniors 2Health News:Youth with IBD are less fit than their peers: McMaster study 2Health News:Haiti Cholera Epidemic Could Sicken 779,000 This Year 2
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
Maximum contact. Minimum wear. Outstanding results....
... knee prosthesis stems from many years of ... manufacturing technologies have been used in order ... as a favorable pressure distribution pattern on ... to a minimum. The inherent design of ...
...
Medicine Products: